These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 6219479

  • 1. Function and migration of suppressor lymphocytes from cyclosporine-treated heart graft recipients.
    Bordes-Aznar J, Kupiec-Weglinski JW, Duarte AJ, Milford EL, Strom TB, Tilney NL.
    Transplantation; 1983 Feb; 35(2):185-90. PubMed ID: 6219479
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immune responsiveness following skin grafting in cyclosporine-treated rats.
    Towpik E, Kupiec-Weglinski JW, Uhteg LC, Padberg W, Tilney NL.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):497-8. PubMed ID: 2978916
    [No Abstract] [Full Text] [Related]

  • 6. Tempo of induction of W3/25+ suppressor cells in cyclosporine-treated rat cardiac allograft recipients.
    Hall BM, Gurley KE, Dorsch SE.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):504. PubMed ID: 2978917
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A novel cell type carrying both Th and Tc/s markers in the blood of cyclosporine-treated, allografted rats.
    Godden U, Herbert J, Stewart RD, Roser B.
    Transplantation; 1985 Jun; 39(6):624-8. PubMed ID: 3159136
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive therapy for renal transplantation.
    Carpenter CB, Strom TB.
    Springer Semin Immunopathol; 1984 Jun; 7(1):43-57. PubMed ID: 6234670
    [No Abstract] [Full Text] [Related]

  • 12. The possible role of cytotoxic T cells in the mediation of first-set allograft rejection.
    Hall BM, Gurley KE, Dorsch SE.
    Transplantation; 1985 Sep; 40(3):336-9. PubMed ID: 2930923
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Prolongation of rat hepatic allografts by donor splenocyte infusion and peritransplant cyclosporine treatment].
    Sun JH.
    Zhonghua Wai Ke Za Zhi; 1989 Dec; 27(12):765-7, 783. PubMed ID: 2534594
    [Abstract] [Full Text] [Related]

  • 15. Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype.
    Cranston D, Wood KJ, Carter NP, Morris PJ.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):505. PubMed ID: 2978918
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nature of the suppressor cells mediating prolonged graft survival after administration of extracted histocompatibility antigen and cyclosporine.
    Yoshimura N, Kahan BD.
    Transplantation; 1985 Feb; 39(2):162-8. PubMed ID: 3155879
    [Abstract] [Full Text] [Related]

  • 20. The real meaning of changing peripheral blood helper to cytotoxic/suppressor cell ratio during renal allograft rejection.
    Kovithavongs T, Dossetor JB.
    Transplant Proc; 1984 Dec; 16(6):1486-9. PubMed ID: 6239421
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.